Registry Code	part name	Existing and new	Length(bp)	Compound or basic	Group favorite
BBa_K5482000	CisF3H	new	1086	Basic
BBa_K5482001	CuFLS	new	1005	Basic
BBa_K5482002	CisF3H-CuFLS	new	2315	Compound	yes
BBa_K5482003	F3H-GGGS-FLS	new	2103	Basic	yes
BBa_K5482004	F3H-GGGS2-FLS	new	2115	Basic
BBa_K5482005	F3H-TPTP-FLS	new	2103	Basic
BBa_K5482006	F3H-TPTP2-FLS	new	2115	Basic	yes
BBa_K5482027	F3H-TPTP2-FLS+FLS	new	3126	Compound
BBa_K5482028	F3H-TPTP2-FLS+F3H	new	3207	Compound
BBa_K3769002	GadB	Existing	1398	Basic	yes

Benefits for Future iGEM Teams:

Our work provides a solid foundation for future teams interested in biosynthetic pathways for natural product production. The combination of synthetic biology with traditional medicine not only offers an environmentally friendly and scalable solution for producing bioactive compounds but also highlights the potential of using microorganisms for drug development. Future iGEM teams can build upon our research by further optimizing enzyme pathways, improving yield, or exploring additional applications of these compounds in the food, health, and wellness industries.